Literature DB >> 24192672

RSV frequency in children below 2 years hospitalized for lower respiratory tract infections.

Mustafa Hacımustafaoğlu1, Solmaz Celebi, Sefika Elmas Bozdemir, Taner Ozgür, Ismail Ozcan, Atilla Güray, Deniz Cakır.   

Abstract

Respiratory syncytial virus (RSV) is the most frequent agent of acute lower respiratory diseases and creates a significant burden of disease in children under 5 years all over the world. RSV causes severe lower respiratory tract infections (LRTI) that require hospitalization, especially in children ≤2 years. The aim of this study was to determine the incidence of RSV in children ≤2 years of age hospitalized for LRTI. Children ≤2 years of age hospitalized for one year for LRTI in the three largest hospitals of Bursa City Center, Turkey were evaluated. These three hospitals comprise 67.5% of all child beds in central Bursa, so this study allows us to evaluate the total disease burden and hospitalization incidence in central Bursa. Nasal swabs of the children were evaluated with RSV Respi- Strip (Coris Bioconcept Organization). A total of 671 children were hospitalized for LRTI, and 254 (37.9%) had at least one hospitalization that was positive for RSV. Of all patients with LRTI, 54.8% (368/671) were hospitalized for acute bronchiolitis, while 45.2% (303/671) were hospitalized for pneumonia. Of patients with acute bronchiolitis or pneumonia, 41% (151/368) and 34% (103/303) were RSV+, respectively. Of RSV+ hospitalized children, 59.5% (151/254) were diagnosed as acute bronchiolitis and 40.5% (103/254) as pneumonia. The annual incidences of hospitalization due to LRTI, acute bronchiolitis and pneumonia were 20.5/1000, 11.2/1000 and 9.3/1000, respectively, in children ≤2 years of age. The annual incidences of hospitalization due to RSV+ LRTI, acute bronchiolitis and pneumonia were found as 7.8/1000, 4.6/1000 and 3.2/1000, respectively, in children ≤2 years of age. More than one-third of all children hospitalized with LRTI (38.3%, n=257) were in the 0-3 months age group. Compared to other age groups, RSV positivity was highest in that age group for acute bronchiolitis (57%), pneumonia (39.5%) and also total children with LRTI (47.9%). RSV is a very important cause of lower respiratory infections in children ≤2 years of age and occurred most frequently in those 0-3 months of age in our study. Since there is no other study assessing the annual hospitalization incidence of RSV+LRTIs in one city in Turkey, our study has unique importance for providing valuable statistical data about RSV+LRTIs.

Entities:  

Mesh:

Year:  2013        PMID: 24192672

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  12 in total

1.  Resveratrol protects neuronal cells from isoflurane-induced inflammation and oxidative stress-associated death by attenuating apoptosis via Akt/p38 MAPK signaling.

Authors:  Weilan Hu; Ei Yang; Jianxin Ye; Weili Han; Zeng-Li Du
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

Review 2.  Respiratory syncytial virüs infections in neonates and infants.

Authors:  Yıldız Perk; Mine Özdil
Journal:  Turk Pediatri Ars       Date:  2018-06-01

3.  Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis.

Authors:  M Cetinkaya; T K Oral; S Karatekin; B Cebeci; A Babayigit; Y Yesil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-08       Impact factor: 3.267

4.  Snotwatch: an ecological analysis of the relationship between febrile seizures and respiratory virus activity.

Authors:  Rana Sawires; Martin Kuldorff; Michael Fahey; Hazel Clothier; Jim Buttery
Journal:  BMC Pediatr       Date:  2022-06-22       Impact factor: 2.567

5.  The epidemiologic and clinical features of viral agents among hospitalized children with lower respiratory tract infections.

Authors:  Deniz Aygün; Firuze Erbek; Mert Kuşkucu; Dicle Şener; Muhammet Köşker; Fatih Varol; Kenan Midilli; Haluk Çokuğraş; Yıldız Camcıoğlu
Journal:  Turk Pediatri Ars       Date:  2020-06-19

Review 6.  Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.

Authors:  Louis Bont; Paul A Checchia; Brigitte Fauroux; Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-08-01

Review 7.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

8.  Respiratory syncytial virus a and b display different temporal patterns in a 4-year prospective cross-sectional study among children with acute respiratory infection in a tropical city.

Authors:  Maiara L Bouzas; Juliana R Oliveira; Kiyoshi F Fukutani; Igor C Borges; Aldina Barral; Winke Van der Gucht; Elke Wollants; Marc Van Ranst; Camila I de Oliveira; Johan Van Weyenbergh; Cristiana M Nascimento-Carvalho
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan.

Authors:  Najwa Khuri-Bulos; Lindsey Lawrence; Bhinnata Piya; Li Wang; Christopher Fonnesbeck; Samir Faouri; Asem Shehabi; Sten H Vermund; John V Williams; Natasha B Halasa
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

10.  Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

Authors:  Koen B Pouwels; Sefika E Bozdemir; Selen Yegenoglu; Solmaz Celebi; E David McIntosh; Serhat Unal; Maarten J Postma; Mustafa Hacimustafaoglu
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.